Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.5853
H.R.5853: Gray Market Drug Reform and Transparency Act of 2012
About This Bill
- This bill was introduced in the 112th Congress
- This bill is primarily about health
- Introduced May 22, 2012
- Latest Major Action May 25, 2012
- See the one similar bills introduced in other congresses.
Bill Sponsor
Bill Summary
Gray Market Drug Reform and Transparency Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act to: (1) make it a prohibited act and a misbranding for a wholesale distributor of prescription drugs to purchase or receive a prescription drug from a pharmacy or a pharmacist, (2) require annual reporting by wholesale distributors of prescription drugs, (3) require the Secretary of Health and Human Services (HHS) to establish and maintain a...
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Referred to the House Committee on Energy and Commerce.
|
|
Referred to the Subcommittee on Health.
|
|
May 22, 2012 |
Introduced in the House by Elijah E. Cummings (D-Md.) |